Though A&Z Pharmaceutical has grown steadily over the years, the company’s mission has stayed the same: working diligently to ...

By Christy Santhosh (Reuters) -Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its ...

Brands That Matter panel to examine Purdue-led pharmaceutical transformations ...

Eli Lilly has announced plans to expand its domestic medicine production in the US by establishing four new pharmaceutical ...

As biopharma players continue to parse out what the second Trump Administration means for the industry, Pfizer CEO Albert ...

Eli Lilly and Co. is in negotiations with several states and plans to announce the locations of four new manufacturing plants ...

Eli Lilly plans to spend at least $27 billion to build four new manufacturing plants in the U.S., the drugmaker said at a ...

Eli Lilly is doubling its U.S. manufacturing investment since 2020 as it seeks to produce more drugs domestically. Its latest investment is to the tune of $27 billion.

CEO Albert Bourla said on Monday that the drugmaker could move some of its overseas manufacturing to its U.S. plants if ...

Artificial intelligence improves process control and reduces the time required to produce key products such as the COVID-19 ...

President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.